作者单位：
Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
[1]
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
[2]
Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA 94158, USA.
[3]
Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA 94158, USA.
[4]
Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA 94158, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.
[5]
Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: charles.craik@ucsf.edu.
[6]
DOI
10.1016/j.jbc.2025.108220
PMID
39863102
发布时间
2025-02-08
换一批
换一批
